MDxHealth (MDXH) Reports Prelim Q3 Revenues
FREE Breaking News Alerts from StreetInsider.com!
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
- Needham Starts NeoVolta (NEOV) at Buy
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- SanDisk stock target lifted by Citi on continued demand strength
MDxHealth Reports Preliminary Q3-2023 Revenues
October 9, 2023 4:00 PM EDTNEWS RELEASE INSIDE AND REGULATED INFORMATION9 OCTOBER 2023, 4PM ET / 22:00 CET
         Â
MDxHealth Reports Preliminary Q3-2023 Revenues
IRVINE, CA, and HERSTAL, BELGIUM October 9, 2023 MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today reported preliminary third quarter 2023 revenues, units, and cash position.
For the third quarter ended September 30, 2023, the Company expects to report revenues of approximately $19.3 million, representing an increase of 73% over the same period last year and 15% versus the prior quarter;... More
